Zhengzhou · Henan · Established 1994

Rifamycin APIs, Refined Since 1994

Zhengzhou Minzhong Pharmaceutical develops and manufactures semi-synthetic antibiotic APIs and their formulations. Three decades of focused work on the rifamycin series, backed by Chinese GMP, European COS and DMF documentation.

1994Year Founded
9APIs & Intermediates
2008European COS
2025Kaifeng Site Online
China GMP 2004 / 2009 / 2015 European COS 2008 DMF Holder WC Certificate 2024 National High-Tech Enterprise
Who We Are

A dedicated source for the rifamycin series

Our factory sits on the Zhengbian Industrial Belt in the Zhengzhou Economic and Technological Development Zone, next to National Highway 107, the Beijing-Hong Kong-Macau Expressway and the Longhai Railway, just 11 km from Zhengzhou Xinzheng International Airport.

Since 1994 we have concentrated on the research, production and sale of rifamycin products. Our independently developed new process for Rifapentine holds a national patent, won the Henan Province prize for major scientific and technological progress in 2003, and was named a National Key New Product in 2005.

Read Our Story
Focused Portfolio

Six finished APIs and three high-purity rifamycin intermediates, all with CAS numbers.

Patented Process

Proprietary Rifapentine production process, nationally patented and export-listed.

GMP Workshops

Highly automated GMP standard workshops with modern stainless steel equipment.

Analytical Capability

Advanced Hewlett-Packard microelectronic inspection and detection instruments.

Research Partners

Long-term cooperation with Sichuan Antibiotics Research Institute, China Medical Group and Zhengzhou University.

Global Registration

Products registered in India, Ukraine, Russia, Brazil and Mexico, exported to Southeast Asia and Europe.

Product Portfolio

From rifamycin intermediates to finished APIs

A compact, fully traceable rifamycin value chain. Rifamycin Sodium and Rifampicin hold Chinese approval numbers, GMP certification and DMF documentation.

Active Pharmaceutical Ingredients

Supplied for formulation manufacturing with full regulatory documentation.

RifampicinCAS 13292-46-1

Flagship first-line anti-tuberculosis API.

Rifamycin SodiumCAS 14897-39-3

Fermentation-derived sodium salt, GMP certified since 2004.

RifapentineCAS 61379-65-5

Long-acting rifamycin; European COS certification in 2008.

RifaximinCAS 80621-81-4

Non-absorbed rifamycin derivative for GI applications.

RifabutinCAS 72559-06-9

Rifamycin S derivative for mycobacterial infections.

PiroxicamCAS 36322-90-4

NSAID API in the broader product range.

Intermediates

High-purity building blocks for downstream rifamycin synthesis.

Rifamycin SCAS 13553-79-2

Core oxidation intermediate of the series.

Rifamycin OCAS 14487-05-9

Key precursor for semi-synthetic derivatives.

Rifamycin S SodiumCAS 133956-65-7

Sodium salt intermediate, also called Sodium Rifamycin S.

View Full Product List
Quality & Compliance

A compliance record built over three decades

From the first GMP certificate to European COS, DMF and Written Confirmation, every milestone widened the markets our partners can serve.

2004Rifamycin Sodium and Rifampicin passed the first Chinese GMP certification.
2008Rifapentine obtained European COS certification.
2009GMP recertification passed (Certificate Yu K0098).
2015New-version Chinese GMP certification achieved.
2020Production licence renewed; GMP compliance documents obtained.
2024Written Confirmation (WC) certificate obtained for Rifamycin Sodium.
Certificates & Milestones

What buyers can expect

  • GMP-controlled manufacture in automated standard workshops
  • DMF and COS documentation for regulated market filings
  • Modern stainless steel production equipment
  • Advanced chromatographic and microelectronic analysis
  • Batch documentation and full traceability
  • Support for customer audits and specification review

Registered markets

  1. India
  2. Ukraine
  3. Russia
  4. Brazil
  5. Mexico
  6. Southeast Asia and Europe
Manufacturing Footprint

Three decades in Zhengzhou, a new site in Kaifeng

Besides the Zhengzhou development-zone base, production is now also running at Kaifeng Minzhong Pharmaceutical in the Kaifeng Fine Chemical Development Zone, expanding capacity for global partners.

IndiaUkraineRussiaBrazil MexicoSoutheast AsiaEuropeChina

Looking for a reliable Rifampicin API partner?

Send us your specification, DMF request or audit enquiry. Our international team responds quickly.

Request a Quote
© 2026 Zhengzhou Minzhong Pharmaceutical Co., Ltd. All rights reserved. Zhengzhou Economic and Technological Development Zone, Henan, China · +86-371-65797114
Showing posts with label acid-fast bacillus. Show all posts
Showing posts with label acid-fast bacillus. Show all posts

Mycobacterium tuberculosis characteristics: a complete guide

Zhengzhou Minzhong Pharmaceutical Co Ltd | Leading Rifamycin API Manufacturer Since 1994

My Instagram